文献速递肝病

全球及各国青少年非酒精性脂肪性肝病患病率:2019年全球疾病负担研究分析

Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019.
PubMed 文献 · Hepatology · 2023-04-10

该研究分析2019年全球疾病负担研究数据,比较全球、各大洲及各国青少年非酒精性脂肪性肝病(NAFLD)患病率及其与代谢状况和人类发展指数(HDI)的关联。全球青少年NAFLD患病率从1990年的3.73%升至2019年的4.71%(相对增加26.27%),仅高体重指数而非2型糖尿病与全球青少年NAFLD患病率相关。

要点

  • 全球青少年NAFLD患病率从1990年3.73%升至2019年4.71%,相对增加26.27%。
  • 2019年男性患病率5.84%、女性3.52%;大洋洲和北美洲最高,欧洲最低。
  • 仅高体重指数而非2型糖尿病与全球青少年NAFLD患病率相关。

核心结论

  • 青少年NAFLD在所有大洲都是日益严重的健康问题。
  • 改善环境因素(包括生活方式及医疗政策)有助于预防儿童和青少年发生NAFLD并改善其结局。

研究设计与样本

  • 分析2019年全球疾病负担研究数据,比较全球、各大洲及各国青少年NAFLD患病率及其与其他代谢状况和HDI的关联。

主要发现

  • 全球青少年NAFLD患病率从1990年的3.73%升至2019年的4.71%,相对增加26.27%。
  • 2019年男性患病率为5.84%,女性为3.52%。
  • 大洋洲和北美洲青少年NAFLD患病率最高(中位数分别为6.54%和5.64%),欧洲最低(中位数3.98%)。
  • 1990年至2019年南美洲和北美洲青少年NAFLD患病率相对增幅最高(中位数分别为39.25%和36.87%)。
  • 全球青少年高体重指数和2型糖尿病均显著增加,但仅高体重指数而非2型糖尿病与全球青少年NAFLD患病率相关。

关键数值与推荐

  • HDI较高的国家1990年至2019年青少年NAFLD患病率增幅较大,但HDI最高(HDI>0.9)的国家2019年NAFLD患病率最低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: NAFLD in adolescents is an increasing health crisis worldwide, but its exact global, continental, and national prevalence, its relationship with other metabolic conditions, and the human development index (HDI) globally are not known. APPROACH AND RESULTS: We analyzed data from the Global Burden of Disease Study 2019 to compare global, continental, and national prevalence rates of adolescent NAFLD and associations with other metabolic conditions and HDI. The global NAFLD prevalence in adolescents increased from 3.73% in 1990 to 4.71% in 2019 (a relative increase of 26.27%). The prevalence for the male and female populations was 5.84% and 3.52% in 2019, respectively. The Oceanian and North American continents had the highest adolescent NAFLD prevalence (median: 6.54% and 5.64%, respectively), whereas Europe had the lowest prevalence (median: 3.98%). South America and North America had the highest relative increase in adolescent NAFLD prevalence from 1990 to 2019 (median: 39.25% and 36.87%, respectively). High body mass index and type 2 diabetes mellitus increased significantly in adolescents worldwide. However, only high body mass index and not type 2 diabetes mellitus correlated with NAFLD prevalence in adolescents globally. Countries with a higher HDI had larger increases in adolescent NAFLD prevalence from 1990 to 2019 although countries with the highest HDI (HDI: > 0.9) had the lowest NAFLD prevalence in 2019. CONCLUSIONS: NAFLD in adolescents is an increasing health problem on all continents. Improving environmental factors, including lifestyle but also healthcare policies, can help to prevent NAFLD from developing in children and adolescents and help to improve outcomes in children and adolescents with NAFLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Hartmann P, Zhang X, Loomba R, et al. Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019. Hepatology. 2023. PMID: 37021791. doi:10.1097/HEP.0000000000000383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。